Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-13

Clinical Trial Update: A Study of Vedolizumab in Adults With Crohn's Disease (CD)

View source ↗

Summary

A completed clinical trial evaluating Vedolizumab in adults with Crohn's disease has finished (NCT05192863). The study was sponsored by Takeda.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vedolizumab (vedolizumab)

Snippet

Sponsor: Takeda | Conditions: Crohn's Disease | Status: COMPLETED